DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Prasterone
Prasterone
Properties and Units in Clinical Pharmacology and Toxicology
UFC PROHIBITED LIST Effective June 1, 2021 the UFC PROHIBITED LIST
Safety Data Sheet
A10 Anabolic Steroids Hardcore Info
Intrarosa™ (Prasterone)
Assessment Report for Zytiga (Abiraterone) Procedure
DHEA Sulfate, and Aging: Contribution of the Dheage Study to a Sociobiomedical Issue
Honey, Not Tonight; I Have a Headache
New Medicine Assessment Prasterone (Intrarosa®) 6.5 Mg
Anti-Doping Manual Revised Dec. 2018
Stembook 2018.Pdf
ARCI Uniform Classification Guidelines for Foreign Substances, Or Similar State Regulatory Guidelines, Shall Be Assigned Points As Follows
Management of Genitourinary Syndrome of Menopause in Women
90-Day Extended Supply Medications (PDF)
2021 Equine Prohibited Substances List
Pharmacological Drugs Inducing Ototoxicity, Vestibular Symptoms and Tinnitus: a Reasoned and Updated Guide
Maintenance Drug List
Poster Abstracts
Top View
Processes for the Preparation Of
Anti-Doping Convention
Prasterone (Intrarosa) Reference Number: CP.PMN.99 Effective Date: 12.20.16 Revision Log Last Review Date: 02.20 Line of Business: Commercial, Medicaid
Anabolic Steroid Abuse: Psychiatric and Physical Costs
Proquest Dissertations
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Hormonal Profile of Menopausal Women Receiving
HORMONES and SPORT Drugs in Sport – the Role of the Physician
Pharmacologic Treatment Possibilities Disclosures the Neurobiology Of
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Banned Substances
Examples of Prohibited and Permitted Substances And
INTRAROSA (Prasterone) Vaginal Insert Is a Vaginally Administered Steroid
ARCI CLASSIFICATION PROGRAM V14.1
Apis and Intermediates Put Pfizer Centreone in Your Corner Can I Source My Steroid Apis Or Intermediates Direct from Pfizer?
Study Protocol and Statistical Analysis Plan
1. INTRAROSA® Product Monograph. Endoceutics, Inc. October 2019
Prasterone (Intrarosa) for Dyspareunia
Articles Safety and Efficacy of Testosterone for Women
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
WADA 2018 Prohibited List
German Medicinal Products Act (Arzneimittelgesetz
01 Stockley's Herbal Medicines Interactions PRELIMS 1
Mesh Terms for 2002
The Clinical Utility of Compounded Bioidentical Hormone Therapy: a Review of Safety, Effectiveness, and Use (2020)
An Overview of Dehydroepiandrosterone (EM-760) As a Treatment Option for Genitourinary Syndrome of Menopause
2017 Prohibited List
Prasterone, a New Option in the Treatment of Lichen Sclerosus? a Case Report and Discussion
AHFS Pharmacologic-Therapeutic Classification System
FEP 5 Tier Managed Rx Drug Formulary (807) Basic Option
2020 Prohibited List
2124 Sex Hormones and Their Modulators
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
GC–MS Quantitative Analysis of Black Market Pharmaceutical Products
Intrarosa, INN-Prasterone
Pharmaceutical Appendix to the Tariff Schedule 2
Anabolic Steroid Abuse: Psychiatric and Physical Costs
Substance Activity
208470Orig1s000
Effects of Different Menopause Hormone Therapy Routes of Administration on Insulin Levels in Early Menopausal Non-Diabetic Subjects
The Effects of Treatment with Prasterone (Dhea) on Circulating Hormones, Body Composition and Muscle Strength in Men and Women